カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のブロッキングペプチド市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Blocking Peptides Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17219）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17219
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のブロッキングペプチド市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ブロッキングペプチド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のブロッキングペプチドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ブロッキングペプチド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・SSX2ブロッキングペプチド、KLK2ブロッキングペプチド、FZD4ブロッキングペプチド、SPDEFブロッキングペプチド、その他

用途別セグメントは次のように区分されます。
・免疫療法、化学分析、その他

世界のブロッキングペプチド市場の主要な市場プレーヤーは以下のとおりです。
・amsbio、Abcam、Fitzgerald Industries International、Aviva Systems Biology、Alomone Labs、Merck、Abcepta

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ブロッキングペプチド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なブロッキングペプチドメーカーの企業概要、2019年～2022年までのブロッキングペプチドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なブロッキングペプチドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ブロッキングペプチドの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのブロッキングペプチドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのブロッキングペプチド市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびブロッキングペプチドの産業チェーンを掲載しています。
・第13、14、15章では、ブロッキングペプチドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ブロッキングペプチドの概要
- 種類別分析（2017年vs2021年vs2028年）：SSX2ブロッキングペプチド、KLK2ブロッキングペプチド、FZD4ブロッキングペプチド、SPDEFブロッキングペプチド、その他
- 用途別分析（2017年vs2021年vs2028年）：免疫療法、化学分析、その他
- 世界のブロッキングペプチド市場規模・予測
- 世界のブロッキングペプチド生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- amsbio、Abcam、Fitzgerald Industries International、Aviva Systems Biology、Alomone Labs、Merck、Abcepta
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：SSX2ブロッキングペプチド、KLK2ブロッキングペプチド、FZD4ブロッキングペプチド、SPDEFブロッキングペプチド、その他
・用途別分析2017年-2028年：免疫療法、化学分析、その他
・ブロッキングペプチドの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ブロッキングペプチドのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ブロッキングペプチドのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ブロッキングペプチドの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ブロッキングペプチドの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Blocking Peptides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Blocking Peptides market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunity Therapy accounting for % of the Blocking Peptides global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While SSX2 Blocking Peptide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Blocking Peptides include amsbio, Abcam, Fitzgerald Industries International, Aviva Systems Biology, and Alomone Labs, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Blocking Peptides market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
SSX2 Blocking Peptide
KLK2 Blocking Peptide
FZD4 Blocking Peptide
SPDEF Blocking Peptide
Others
Market segment by Application can be divided into
Immunity Therapy
Chemical Analysis
Others
The key market players for global Blocking Peptides market are listed below:
amsbio
Abcam
Fitzgerald Industries International
Aviva Systems Biology
Alomone Labs
Merck
Abcepta
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blocking Peptides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Blocking Peptides, with price, sales, revenue and global market share of Blocking Peptides from 2019 to 2022.
Chapter 3, the Blocking Peptides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blocking Peptides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Blocking Peptides market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blocking Peptides.
Chapter 13, 14, and 15, to describe Blocking Peptides sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Blocking Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blocking Peptides Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 SSX2 Blocking Peptide
1.2.3 KLK2 Blocking Peptide
1.2.4 FZD4 Blocking Peptide
1.2.5 SPDEF Blocking Peptide
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Blocking Peptides Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunity Therapy
1.3.3 Chemical Analysis
1.3.4 Others
1.4 Global Blocking Peptides Market Size & Forecast
1.4.1 Global Blocking Peptides Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Blocking Peptides Sales in Volume (2017-2028)
1.4.3 Global Blocking Peptides Price (2017-2028)
1.5 Global Blocking Peptides Production Capacity Analysis
1.5.1 Global Blocking Peptides Total Production Capacity (2017-2028)
1.5.2 Global Blocking Peptides Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Blocking Peptides Market Drivers
1.6.2 Blocking Peptides Market Restraints
1.6.3 Blocking Peptides Trends Analysis
2 Manufacturers Profiles
2.1 amsbio
2.1.1 amsbio Details
2.1.2 amsbio Major Business
2.1.3 amsbio Blocking Peptides Product and Services
2.1.4 amsbio Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abcam
2.2.1 Abcam Details
2.2.2 Abcam Major Business
2.2.3 Abcam Blocking Peptides Product and Services
2.2.4 Abcam Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fitzgerald Industries International
2.3.1 Fitzgerald Industries International Details
2.3.2 Fitzgerald Industries International Major Business
2.3.3 Fitzgerald Industries International Blocking Peptides Product and Services
2.3.4 Fitzgerald Industries International Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aviva Systems Biology
2.4.1 Aviva Systems Biology Details
2.4.2 Aviva Systems Biology Major Business
2.4.3 Aviva Systems Biology Blocking Peptides Product and Services
2.4.4 Aviva Systems Biology Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Alomone Labs
2.5.1 Alomone Labs Details
2.5.2 Alomone Labs Major Business
2.5.3 Alomone Labs Blocking Peptides Product and Services
2.5.4 Alomone Labs Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Blocking Peptides Product and Services
2.6.4 Merck Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Abcepta
2.7.1 Abcepta Details
2.7.2 Abcepta Major Business
2.7.3 Abcepta Blocking Peptides Product and Services
2.7.4 Abcepta Blocking Peptides Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Blocking Peptides Breakdown Data by Manufacturer
3.1 Global Blocking Peptides Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Blocking Peptides Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Blocking Peptides
3.4 Market Concentration Rate
3.4.1 Top 3 Blocking Peptides Manufacturer Market Share in 2021
3.4.2 Top 6 Blocking Peptides Manufacturer Market Share in 2021
3.5 Global Blocking Peptides Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Blocking Peptides Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Blocking Peptides Market Size by Region
4.1.1 Global Blocking Peptides Sales in Volume by Region (2017-2028)
4.1.2 Global Blocking Peptides Revenue by Region (2017-2028)
4.2 North America Blocking Peptides Revenue (2017-2028)
4.3 Europe Blocking Peptides Revenue (2017-2028)
4.4 Asia-Pacific Blocking Peptides Revenue (2017-2028)
4.5 South America Blocking Peptides Revenue (2017-2028)
4.6 Middle East and Africa Blocking Peptides Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Blocking Peptides Sales in Volume by Type (2017-2028)
5.2 Global Blocking Peptides Revenue by Type (2017-2028)
5.3 Global Blocking Peptides Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Blocking Peptides Sales in Volume by Application (2017-2028)
6.2 Global Blocking Peptides Revenue by Application (2017-2028)
6.3 Global Blocking Peptides Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Blocking Peptides Sales by Type (2017-2028)
7.2 North America Blocking Peptides Sales by Application (2017-2028)
7.3 North America Blocking Peptides Market Size by Country
7.3.1 North America Blocking Peptides Sales in Volume by Country (2017-2028)
7.3.2 North America Blocking Peptides Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Blocking Peptides Sales by Type (2017-2028)
8.2 Europe Blocking Peptides Sales by Application (2017-2028)
8.3 Europe Blocking Peptides Market Size by Country
8.3.1 Europe Blocking Peptides Sales in Volume by Country (2017-2028)
8.3.2 Europe Blocking Peptides Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Blocking Peptides Sales by Type (2017-2028)
9.2 Asia-Pacific Blocking Peptides Sales by Application (2017-2028)
9.3 Asia-Pacific Blocking Peptides Market Size by Region
9.3.1 Asia-Pacific Blocking Peptides Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Blocking Peptides Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Blocking Peptides Sales by Type (2017-2028)
10.2 South America Blocking Peptides Sales by Application (2017-2028)
10.3 South America Blocking Peptides Market Size by Country
10.3.1 South America Blocking Peptides Sales in Volume by Country (2017-2028)
10.3.2 South America Blocking Peptides Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Blocking Peptides Sales by Type (2017-2028)
11.2 Middle East & Africa Blocking Peptides Sales by Application (2017-2028)
11.3 Middle East & Africa Blocking Peptides Market Size by Country
11.3.1 Middle East & Africa Blocking Peptides Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Blocking Peptides Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Blocking Peptides and Key Manufacturers
12.2 Manufacturing Costs Percentage of Blocking Peptides
12.3 Blocking Peptides Production Process
12.4 Blocking Peptides Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Blocking Peptides Typical Distributors
13.3 Blocking Peptides Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Blocking Peptides Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Blocking Peptides Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. amsbio Basic Information, Manufacturing Base and Competitors
Table 4. amsbio Major Business
Table 5. amsbio Blocking Peptides Product and Services
Table 6. amsbio Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Abcam Basic Information, Manufacturing Base and Competitors
Table 8. Abcam Major Business
Table 9. Abcam Blocking Peptides Product and Services
Table 10. Abcam Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Fitzgerald Industries International Basic Information, Manufacturing Base and Competitors
Table 12. Fitzgerald Industries International Major Business
Table 13. Fitzgerald Industries International Blocking Peptides Product and Services
Table 14. Fitzgerald Industries International Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aviva Systems Biology Basic Information, Manufacturing Base and Competitors
Table 16. Aviva Systems Biology Major Business
Table 17. Aviva Systems Biology Blocking Peptides Product and Services
Table 18. Aviva Systems Biology Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Alomone Labs Basic Information, Manufacturing Base and Competitors
Table 20. Alomone Labs Major Business
Table 21. Alomone Labs Blocking Peptides Product and Services
Table 22. Alomone Labs Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Blocking Peptides Product and Services
Table 26. Merck Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Abcepta Basic Information, Manufacturing Base and Competitors
Table 28. Abcepta Major Business
Table 29. Abcepta Blocking Peptides Product and Services
Table 30. Abcepta Blocking Peptides Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Blocking Peptides Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Blocking Peptides Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Blocking Peptides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Blocking Peptides Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Blocking Peptides Production Site of Key Manufacturer
Table 36. Blocking Peptides New Entrant and Capacity Expansion Plans
Table 37. Blocking Peptides Mergers & Acquisitions in the Past Five Years
Table 38. Global Blocking Peptides Sales by Region (2017-2022) & (K Units)
Table 39. Global Blocking Peptides Sales by Region (2023-2028) & (K Units)
Table 40. Global Blocking Peptides Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Blocking Peptides Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Blocking Peptides Sales by Type (2017-2022) & (K Units)
Table 43. Global Blocking Peptides Sales by Type (2023-2028) & (K Units)
Table 44. Global Blocking Peptides Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Blocking Peptides Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Blocking Peptides Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Blocking Peptides Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Blocking Peptides Sales by Application (2017-2022) & (K Units)
Table 49. Global Blocking Peptides Sales by Application (2023-2028) & (K Units)
Table 50. Global Blocking Peptides Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Blocking Peptides Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Blocking Peptides Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Blocking Peptides Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Blocking Peptides Sales by Country (2017-2022) & (K Units)
Table 55. North America Blocking Peptides Sales by Country (2023-2028) & (K Units)
Table 56. North America Blocking Peptides Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Blocking Peptides Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Blocking Peptides Sales by Type (2017-2022) & (K Units)
Table 59. North America Blocking Peptides Sales by Type (2023-2028) & (K Units)
Table 60. North America Blocking Peptides Sales by Application (2017-2022) & (K Units)
Table 61. North America Blocking Peptides Sales by Application (2023-2028) & (K Units)
Table 62. Europe Blocking Peptides Sales by Country (2017-2022) & (K Units)
Table 63. Europe Blocking Peptides Sales by Country (2023-2028) & (K Units)
Table 64. Europe Blocking Peptides Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Blocking Peptides Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Blocking Peptides Sales by Type (2017-2022) & (K Units)
Table 67. Europe Blocking Peptides Sales by Type (2023-2028) & (K Units)
Table 68. Europe Blocking Peptides Sales by Application (2017-2022) & (K Units)
Table 69. Europe Blocking Peptides Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Blocking Peptides Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Blocking Peptides Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Blocking Peptides Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Blocking Peptides Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Blocking Peptides Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Blocking Peptides Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Blocking Peptides Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Blocking Peptides Sales by Application (2023-2028) & (K Units)
Table 78. South America Blocking Peptides Sales by Country (2017-2022) & (K Units)
Table 79. South America Blocking Peptides Sales by Country (2023-2028) & (K Units)
Table 80. South America Blocking Peptides Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Blocking Peptides Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Blocking Peptides Sales by Type (2017-2022) & (K Units)
Table 83. South America Blocking Peptides Sales by Type (2023-2028) & (K Units)
Table 84. South America Blocking Peptides Sales by Application (2017-2022) & (K Units)
Table 85. South America Blocking Peptides Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Blocking Peptides Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Blocking Peptides Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Blocking Peptides Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Blocking Peptides Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Blocking Peptides Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Blocking Peptides Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Blocking Peptides Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Blocking Peptides Sales by Application (2023-2028) & (K Units)
Table 94. Blocking Peptides Raw Material
Table 95. Key Manufacturers of Blocking Peptides Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Blocking Peptides Typical Distributors
Table 99. Blocking Peptides Typical Customers
List of Figures
Figure 1. Blocking Peptides Picture
Figure 2. Global Blocking Peptides Revenue Market Share by Type in 2021
Figure 3. SSX2 Blocking Peptide
Figure 4. KLK2 Blocking Peptide
Figure 5. FZD4 Blocking Peptide
Figure 6. SPDEF Blocking Peptide
Figure 7. Others
Figure 8. Global Blocking Peptides Revenue Market Share by Application in 2021
Figure 9. Immunity Therapy
Figure 10. Chemical Analysis
Figure 11. Others
Figure 12. Global Blocking Peptides Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Blocking Peptides Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Blocking Peptides Sales (2017-2028) & (K Units)
Figure 15. Global Blocking Peptides Price (2017-2028) & (US$/Unit)
Figure 16. Global Blocking Peptides Production Capacity (2017-2028) & (K Units)
Figure 17. Global Blocking Peptides Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Blocking Peptides Market Drivers
Figure 19. Blocking Peptides Market Restraints
Figure 20. Blocking Peptides Market Trends
Figure 21. Global Blocking Peptides Sales Market Share by Manufacturer in 2021
Figure 22. Global Blocking Peptides Revenue Market Share by Manufacturer in 2021
Figure 23. Blocking Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Blocking Peptides Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Blocking Peptides Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Blocking Peptides Sales Market Share by Region (2017-2028)
Figure 27. Global Blocking Peptides Revenue Market Share by Region (2017-2028)
Figure 28. North America Blocking Peptides Revenue (2017-2028) & (USD Million)
Figure 29. Europe Blocking Peptides Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Blocking Peptides Revenue (2017-2028) & (USD Million)
Figure 31. South America Blocking Peptides Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Blocking Peptides Revenue (2017-2028) & (USD Million)
Figure 33. Global Blocking Peptides Sales Market Share by Type (2017-2028)
Figure 34. Global Blocking Peptides Revenue Market Share by Type (2017-2028)
Figure 35. Global Blocking Peptides Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Blocking Peptides Sales Market Share by Application (2017-2028)
Figure 37. Global Blocking Peptides Revenue Market Share by Application (2017-2028)
Figure 38. Global Blocking Peptides Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Blocking Peptides Sales Market Share by Type (2017-2028)
Figure 40. North America Blocking Peptides Sales Market Share by Application (2017-2028)
Figure 41. North America Blocking Peptides Sales Market Share by Country (2017-2028)
Figure 42. North America Blocking Peptides Revenue Market Share by Country (2017-2028)
Figure 43. United States Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Blocking Peptides Sales Market Share by Type (2017-2028)
Figure 47. Europe Blocking Peptides Sales Market Share by Application (2017-2028)
Figure 48. Europe Blocking Peptides Sales Market Share by Country (2017-2028)
Figure 49. Europe Blocking Peptides Revenue Market Share by Country (2017-2028)
Figure 50. Germany Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Blocking Peptides Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Blocking Peptides Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Blocking Peptides Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Blocking Peptides Revenue Market Share by Region (2017-2028)
Figure 59. China Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Blocking Peptides Sales Market Share by Type (2017-2028)
Figure 66. South America Blocking Peptides Sales Market Share by Application (2017-2028)
Figure 67. South America Blocking Peptides Sales Market Share by Country (2017-2028)
Figure 68. South America Blocking Peptides Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Blocking Peptides Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Blocking Peptides Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Blocking Peptides Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Blocking Peptides Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Blocking Peptides Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Blocking Peptides in 2021
Figure 80. Manufacturing Process Analysis of Blocking Peptides
Figure 81. Blocking Peptides Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の神経筋遮断薬市場2022年：市場規模予測（～2028年）
  • 世界の標識ペプチド市場2022年：市場規模予測（～2028年）
  • 世界のトランジェントブロッキングユニット（TBU）市場2022年：市場規模予測（～2028年）
  • 世界のルピナスペプチド市場2022年：市場規模予測（～2028年）
  • 世界のカゼイン加水分解ペプチド市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17219 )"世界のブロッキングペプチド市場2022年：市場規模予測（～2028年）" (英文：Global Blocking Peptides Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。